You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Oncol., 22 January 2026

Sec. Pharmacology of Anti-Cancer Drugs

Volume 16 - 2026 | https://doi.org/10.3389/fonc.2026.1771057

Correction: A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancer

  • 1. Institut Roi Albert II, Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium

  • 2. Department of Rhumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium

  • 3. Department of Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium

Article metrics

View details

375

Views

90

Downloads

Author Selda Aydin was omitted as an author in the published article. The correct author list reads:

“Caroline Anthon1,†, Hugo Pierret1,†, Frederic Houssiau2, Selda Aydin3, Astrid De Cuyper1, Cédric Van Marcke1, Marc Van Den Eynde1, Filomena Mazzeo1, Frank Cornelis1, Rachel Galot1, Francois P Duhoux1, Jean-François Baurain1, Emmanuel Seront 1,*

Affiliation 3 “Department of Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium” was omitted for author Selda Aydin. This affiliation has now been added for author Selda Aydin.

The Author Contributions Statement has been corrected to read: “CA: Writing – review & editing, Writing – original draft. HP: Writing – review & editing, Writing – original draft. FH: Writing – original draft, Writing – review & editing. SA: Writing – original draft, Writing – review & editing. AD: Writing – review & editing, Writing – original draft. CV: Writing – review & editing, Writing – original draft. MV: Writing – review & editing, Writing – original draft. FM: Writing – review & editing, Writing – original draft. FC: Writing – review & editing, Writing – original draft. RG: Writing – original draft, Writing – review & editing. FD: Writing – review & editing, Writing – original draft. J-FB: Writing – review & editing, Writing – original draft. ES: Resources, Investigation, Software, Conceptualization, Funding acquisition, Supervision, Writing – review & editing, Data curation, Project administration, Formal Analysis, Writing – original draft, Validation, Methodology, Visualization”.

There was a mistake in Figure 4 as published. There was two parts in the figure as published. The corrected Figure 4 appears below.

There was a mistake in the caption of Figure 4 as published. The caption has some errors in the published version. The corrected caption of Figure 4 appears below.

Figure 4

Figure 4

Renal biopsy demonstrating histological features of thrombotic microangiopathy (Periodic Acid–Schiff staining, magnification ×35). The glomeruli exhibit duplication of the glomerular basement membrane (red arrow) associated with endothelial swelling. Segmental ischemic lesion (green arrow) and mesangiolysis (blue arrow) are consistent with acute thrombotic microangiopathy.

“Renal biopsy demonstrating histological features of thrombotic microangiopathy (Periodic Acid–Schiff staining, magnification ×35). The glomeruli exhibit duplication of the glomerular basement membrane (red arrow) associated with endothelial swelling. Segmental ischemic lesion (green arrow) and mesangiolysis (blue arrow) are consistent with acute thrombotic microangiopathy”

The original version of this article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

immune checkpoint inhibitor, thrombotic microangiopathy, scleroderma renalcrisis, immune-related adverse event, systemic sclerosis

Citation

Anthon C, Pierret H, Houssiau F, Aydin S, De Cuyper A, Van Marcke C, Van Den Eynde M, Mazzeo F, Cornelis F, Galot R, Duhoux FP, Baurain J-F and Seront E (2026) Correction: A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancer. Front. Oncol. 16:1771057. doi: 10.3389/fonc.2026.1771057

Received

18 December 2025

Revised

30 December 2025

Accepted

09 January 2026

Published

22 January 2026

Volume

16 - 2026

Edited and reviewed by

Gian Marco Ghiggeri, Giannina Gaslini Institute (IRCCS), Italy

Updates

Copyright

*Correspondence: Emmanuel Seront,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics